219 related articles for article (PubMed ID: 15761249)
1. Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung.
Lee YS; Byun J; Kim JA; Lee JS; Kim KL; Suh YL; Kim JM; Jang HS; Lee JY; Shin IS; Suh W; Jeon ES; Kim DK
Exp Mol Med; 2005 Feb; 37(1):27-35. PubMed ID: 15761249
[TBL] [Abstract][Full Text] [Related]
2. [Expression of connective tissue growth factor and its down-regulation by simvastatin administration in pulmonary hypertensive rats].
Liu B; Wang XM; Zhou TF; Hua YM; Liu HM; Wei L; Qiao LN; Wang XQ; Zhao SS; Shi K
Zhonghua Er Ke Za Zhi; 2008 May; 46(5):359-65. PubMed ID: 19099753
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
4. Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Wei C; Kim IK; Li L; Wu L; Gupta S
PLoS One; 2014; 9(11):e110598. PubMed ID: 25412097
[TBL] [Abstract][Full Text] [Related]
5. Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling.
Ahmed MS; Øie E; Vinge LE; von Lueder TG; Attramadal T; Attramadal H
Cardiovasc Res; 2007 May; 74(2):323-33. PubMed ID: 17254558
[TBL] [Abstract][Full Text] [Related]
6. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.
Finckenberg P; Inkinen K; Ahonen J; Merasto S; Louhelainen M; Vapaatalo H; Müller D; Ganten D; Luft F; Mervaala E
Am J Pathol; 2003 Jul; 163(1):355-66. PubMed ID: 12819040
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.
Liu B; Wang XQ; Yu L; Zhou TF; Wang XM; Liu HM
Exp Lung Res; 2009 Jun; 35(5):411-26. PubMed ID: 19842842
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
13. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
14. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells.
Liu X; Luo F; Pan K; Wu W; Chen H
BMC Cell Biol; 2007 Jan; 8():1. PubMed ID: 17224075
[TBL] [Abstract][Full Text] [Related]
15. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF.
Pan LH; Yamauchi K; Uzuki M; Nakanishi T; Takigawa M; Inoue H; Sawai T
Eur Respir J; 2001 Jun; 17(6):1220-7. PubMed ID: 11491168
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Yip HK
Circ J; 2008 May; 72(5):825-31. PubMed ID: 18441466
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
[TBL] [Abstract][Full Text] [Related]
18. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
Kodavanti UP; Jackson MC; Ledbetter AD; Richards JR; Gardner SY; Watkinson WP; Campen MJ; Costa DL
J Toxicol Environ Health A; 1999 Aug; 57(8):543-63. PubMed ID: 10515573
[TBL] [Abstract][Full Text] [Related]
19. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
Wang Y; Zhang XH; Wang HL
Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
[TBL] [Abstract][Full Text] [Related]
20. [Changes of TGF-β1 and CTGF in rats with increased blood flow-induced pulmonary artery hypertension].
Zhu R; He L; Xu J; Zhang Y; Hu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 37(10):1013-20. PubMed ID: 23117454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
